Delivering Personalized Oncology
Systems Biology enabled individualized risk assessment and therapy matching.
Systems approach to personalized medicine
A systems approach will enable “patient-centric” paradigm for personalized, precision oncology.
Sygnomics uses SYstems Genetic Network AnaLysis (SYGNAL) technology to accurately predict risk of disease progression and rank prioritize therapies that target specific cancer-driving gene networks in an individual patient.
Current State of Precision Oncology (2021)
Science and Clinical Partners
Testimonials
This is an incredibly useful tool! I don’t know of any tool like this that oncologists can use to effortlessly explore evidence from disparate sources, all put into the context of risk probability and therapies matched to the molecular characteristics of a single patient. I foresee enormous value for this tool as a subscription service for at least three types of customers: clinical researchers, oncologists and even patients.